Cafepharma Today

June 11 2025 - BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
BMS expands radiopharma pipeline via RayzeBio's $1.3B prostate cancer drug deal
Novo Nordisk, Deep Apple launch drug discovery alliance for weight loss oral therapies
Eli Lilly works out $650M Juvena pact to find muscle-boosting drugs
Nvidia announces massive new initiatives in pharma and clinical research
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Medtronic wins a round in patent spat with Edwards Lifesciences
Mass Device
Wednesday, September 18, 2013 - 11:47am
tags:
Medtronic, patents, Edwards Lifesciences, devices, heart valves
Update on Arena/Eisai's Belviq
Yahoo/Zacks
Wednesday, September 18, 2013 - 11:39am
tags:
Arena Pharmaceuticals, Belviq, obesity, Eisai
Repros reported additional topline results from study for Androxal
Yahoo/Fly on the Wall
Wednesday, September 18, 2013 - 10:37am
tags:
Androxal, Repros Therapeutics, testosterone
Is the Tide About to Turn in the Fight Against Chronic Lymphocytic Leukemia?
Motley Fool
Wednesday, September 18, 2013 - 10:34am
tags:
chronic lymphocytic leukemia, Sanofi, Campath, GSK, Arzerra, Roche, Rituxan, ibrutinib, Pharmacyclics, obinutuzumab, JNJ, Genmab
Top 10 rheumatoid arthritis drugs 2013
Fierce Pharma
Wednesday, September 18, 2013 - 10:27am
tags:
rheumatoid arthritis, Humira, AbbVie, Enbrel, Amgen, Remicade, Janssen, Celebrex, Pfizer, Bristol-Myers Squibb, Orencia, Cimza, UCB, Simponi, JNJ, Arthrotec, Vimovo, AstraZeneca, Kineret
Teva Copy to Boost Billionaire-Backed Drugmaker: Corporate India
Bloomberg
Wednesday, September 18, 2013 - 10:23am
tags:
Copaxone, MS, multiple sclerosis, Teva, India, Natco
CytRx Corporation Remains An Undiscovered Opportunity In The Cancer Space
Seeking Alpha
Wednesday, September 18, 2013 - 10:21am
tags:
CytRx, cancer
Chantix Does Not Increase Depression Risk? A Pfizer Study Says Yes
Pharmalot
Wednesday, September 18, 2013 - 10:15am
tags:
Chantix, Pfizer, depression, smoking cessation
What's MannKind Really Worth?
Motley Fool
Wednesday, September 18, 2013 - 8:51am
tags:
MannKind, Afrezza, diabetes
Teva: A Frustrating Company
Seeking Alpha
Wednesday, September 18, 2013 - 8:48am
tags:
Teva
Analysis: Bribery scandal dents Big Pharma sales in China, GSK hardest hit
Yahoo/Reuters
Wednesday, September 18, 2013 - 8:48am
tags:
China, GSK
AstraZeneca says FDA accepts application for Epanova
The Fly on the Wall
Wednesday, September 18, 2013 - 8:46am
tags:
AstraZeneca, FDA, Epanova, hypertriglyceridemia
IPO Preview: Five Prime Therapeutics
Seeking Alpha
Tuesday, September 17, 2013 - 6:06pm
tags:
IPOs, Five Prime
Clovis Oncology Said to Explore Sale of Biotech Company
Bloomberg
Tuesday, September 17, 2013 - 4:37pm
tags:
Clovis Oncology, M&A
Aging population to fuel big leap in cancer cases--and drug sales
Fierce Pharma
Tuesday, September 17, 2013 - 12:36pm
tags:
cancer, aging, Roche, Celgene, GSK, Novartis, Pfizer, Bayer
Dendreon jumps on winning European approval for prostate-cancer treatment
Marketwatch
Tuesday, September 17, 2013 - 12:34pm
tags:
Europe, prostate cancer, Dendreon, Provenge
KV Pharmaceutical Company Completes Reorganization And Successfully Emerges From Chapter 11 With $375 Million Recapitalization
Marketwatch
Tuesday, September 17, 2013 - 12:26pm
tags:
KV Pharmaceutical, bankruptcy, reorganization
[video]Patent Expirations AbbVie Investors Need to Watch
Motley Fool
Tuesday, September 17, 2013 - 11:49am
tags:
AbbVie, Humira, patents, patent expirations
Will the Exelixis Hype Catch Up to Its Valuation?
Motley Fool
Tuesday, September 17, 2013 - 11:04am
tags:
Exelixis, Cometriq, medullary thyroid cancer
Arthrex asks Supreme Court to hear appeal in $85M loss to Smith & Nephew
Mass Device
Tuesday, September 17, 2013 - 10:53am
tags:
Supreme Court, Smith & Nephew, Arthrex, devices, patents

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Novo Nordisk's Canadian Mistake
In the Pipeline
The Bethesda Declaration
In the Pipeline
Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.